Academic literature on the topic 'Dexpramipexolo'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dexpramipexolo.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Dexpramipexolo"
Panch, Sandhya R., Michael Bozik, Thomas Brown, Ulrike Demarco, Jamie Hahn, Alexander Komarov, Tamika Magee, et al. "Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study." Blood 128, no. 22 (December 2, 2016): 1327. http://dx.doi.org/10.1182/blood.v128.22.1327.1327.
Full textPanch, Sandhya R., Michael E. Bozik, Thomas Brown, Michelle Makiya, Calman Prussin, Donald G. Archibald, Gregory T. Hebrank, et al. "Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes." Blood 132, no. 5 (August 2, 2018): 501–9. http://dx.doi.org/10.1182/blood-2018-02-835330.
Full textGleich, Gerald J. "Dexpramipexole: a new antieosinophil drug?" Blood 132, no. 5 (August 2, 2018): 461–62. http://dx.doi.org/10.1182/blood-2018-06-851600.
Full textMignani, Serge, Jean-Pierre Majoral, Jean-François Desaphy, and Giovanni Lentini. "From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies." Molecules 25, no. 15 (July 22, 2020): 3320. http://dx.doi.org/10.3390/molecules25153320.
Full textKuang, Fei Li. "Dexpramipexole: A Potential Non-biologic Alternative for Patients with Eosinophilic Asthma?" US Respiratory & Pulmonary Diseases 7, no. 2 (2022): 36. http://dx.doi.org/10.17925/usrpd.2022.7.2.36.
Full textMuzzi, Mirko, Elisabetta Gerace, Daniela Buonvicino, Elisabetta Coppi, Francesco Resta, Laura Formentini, Riccardo Zecchi, et al. "Dexpramipexole improves bioenergetics and outcome in experimental stroke." British Journal of Pharmacology 175, no. 2 (May 12, 2017): 272–83. http://dx.doi.org/10.1111/bph.13790.
Full textLequien, Valérie. "Le dexpramipexole, une piste prometteuse contre la SLA." Actualités Pharmaceutiques Hospitalières 6, no. 22 (May 2010): 9. http://dx.doi.org/10.1016/s1769-7344(10)70268-7.
Full textKingwell, Katie. "Dexpramipexole shows promise for ALS in phase II trial." Nature Reviews Neurology 8, no. 1 (December 26, 2011): 4. http://dx.doi.org/10.1038/nrneurol.2011.204.
Full textLudolph, Albert. "Dexpramipexol ist bei der Behandlung der ALS nicht wirksam." InFo Neurologie & Psychiatrie 15, no. 12 (December 2013): 32. http://dx.doi.org/10.1007/s15005-013-0696-z.
Full textTang, Lu, Yun-peng Li, Juan Hu, Ai-hua Chen, and Yingli Mo. "Dexpramipexole attenuates myocardial ischemia/reperfusion injury through upregulation of mitophagy." European Journal of Pharmacology 899 (May 2021): 173962. http://dx.doi.org/10.1016/j.ejphar.2021.173962.
Full textDissertations / Theses on the topic "Dexpramipexolo"
Urru, Matteo. "Approcci farmacologici innovativi per il trattamento della cefalea d’abuso di analgesici e per il blocco dei canali al sodio Nav1.8." Doctoral thesis, 2021. http://hdl.handle.net/2158/1227407.
Full textConference papers on the topic "Dexpramipexolo"
Siddiqui, Salman, Michael Bozik, Donald Archibald, Steven Dworetzky, James Mather, Randall Killingsworth, Sergei Ochkur, Elizabeth Jacobsen, Reynold Panettieri, and Calman Prussin. "Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.rct2900.
Full textPrussin, C., R. A. Panettieri, M. E. Bozik, D. G. Archibald, J. L. Mather, and S. Siddiqui. "Oral Dexpramipexole Efficacy in Lowering Blood Eosinophils in Patients with Moderate to Severe Uncontrolled Eosinophilic Asthma: Study Design and Baseline Data from the AS201 Phase 2 Trial." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1359.
Full text